By
ReInvent 2027 is set to return as a major international gathering for the orthotics and prosthetics sector, bringing together more than 200 professionals from over 20 countries around one central objective: redefining what is possible in O&P.
The event is being positioned as more than a conventional conference. Organisers are framing ReInvent 2027 as a meeting point for clinicians, technicians, innovators, and industry stakeholders who want to explore how new ideas, practical technologies, and shared experience can translate into better patient outcomes.
A major part of the appeal will be the opportunity to gain 20+ CEUs with a strong focus on practical clinical value. For attendees, that means education that is not only relevant on paper, but directly connected to day-to-day decision-making, service delivery, and patient care in modern orthotic and prosthetic practice.
ReInvent 2027 will also place a clear spotlight on 3D printing in O&P, reflecting the growing importance of digital workflows across the profession. With hands-on insights, live demonstrations, and discussions around applied technology, the event is expected to offer valuable perspective for professionals looking to better understand where additive manufacturing can deliver real value in clinical and technical settings.
Beyond the educational programme, the conference is designed to encourage global collaboration and knowledge exchange. With delegates expected from more than 20 countries, ReInvent 2027 offers an international platform for sharing challenges, comparing approaches, and exploring how innovation can be adapted across different healthcare systems and service environments.
For IMEA CPO readers, that matters. The future of orthotics and prosthetics will not be shaped by technology alone, but by how effectively the profession connects innovation with practical implementation and measurable patient benefit. Events like ReInvent 2027 create space for exactly that kind of conversation, linking new tools and new thinking with the realities of clinical care and fabrication.
The message behind the event is clear: this is not just another conference appearance on the annual calendar. ReInvent 2027 is being presented as a forum where innovation meets real patient impact, and where the global O&P community comes together to help move the profession forward.
Professionals interested in attending are encouraged to secure their place early here
